Both in Pharmaceuticals
Viridian Therapeutics vs Viking Therapeutics
Over the past year VRDN returned +8.6% and VKTX returned −27.5%; their daily moves had a correlation of 0.36.
VRDN +8.6% VKTX −27.5%Growth of $1, one year, split-adjusted
| Metric | VRDN | VKTX |
|---|---|---|
| Price | $25.15 | $26.09 |
| Market cap | $2.85B | $3.33B |
| Today | −0.59% | −2.76% |
| 1 month | +32.4% | −10.9% |
| 6 months | +34.1% | −16.7% |
| Year to date | −19.2% | −25.8% |
| 1 year | +6.4% | −31.5% |
| Revenue growth (YoY) | +278.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −39726.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 40.1× | — |
| Net cash | $625.7M | $709.2M |
| Dividend yield | — | — |
| Volatility (60d) | 47.3% | 86.7% |
| Short % of float | 18.5% | 22.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).